Kodiak Sciences Inc.
KOD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $26,706 | $25,947 | $11,001 | $8,711 |
| Gross Profit | -$26,706 | -$25,947 | -$11,001 | -$8,711 |
| % Margin | – | – | – | – |
| R&D Expenses | $126,095 | $206,298 | $267,591 | $217,340 |
| G&A Expenses | $0 | $71,023 | $0 | $0 |
| SG&A Expenses | $34,048 | $71,023 | $62,787 | $41,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$25,947 | $0 | $0 |
| Operating Expenses | $160,143 | $251,374 | $330,378 | $258,340 |
| Operating Income | -$186,849 | -$277,321 | -$341,379 | -$267,051 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $10,642 | $16,830 | $7,556 | $61 |
| Pre-Tax Income | -$176,207 | -$260,491 | -$333,823 | -$266,990 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$176,207 | -$260,491 | -$333,823 | -$266,990 |
| % Margin | – | – | – | – |
| EPS | -3.35 | -4.97 | -6.39 | -5.16 |
| % Growth | 32.6% | 22.2% | -23.8% | – |
| EPS Diluted | -3.35 | -4.97 | -6.39 | -5.16 |
| Weighted Avg Shares Out | 52,583 | 52,414 | 52,250 | 51,789 |
| Weighted Avg Shares Out Dil | 52,583 | 52,414 | 52,250 | 51,789 |
| Supplemental Information | – | – | – | – |
| Interest Income | $11,148 | $16,733 | $7,071 | $298 |
| Interest Expense | $0 | $13 | $18 | $22 |
| Depreciation & Amortization | $26,706 | $25,947 | $11,001 | $8,711 |
| EBITDA | -$149,501 | -$234,531 | -$322,804 | -$258,257 |
| % Margin | – | – | – | – |